Search
-
News
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.
… Saturday, June 2, 2007 Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy
-
News
Medical oncologist Ping Chi has been named an incumbent of a Geoffrey Beene Junior Faculty Chair, a position designed to provide funding to outstanding young researchers at a crucial early stage in their careers.
… Thursday, March 1, 2012 Summary Medical oncologist Ping Chi has been named an incumbent of a Geoffrey Beene Junior Faculty Chair, a position designed to provide funding to outstanding young researchers at a crucial early stage in their careers. Ping Chi has been named an incumbent of a Geoffrey Beene
-
2023 Annual Report
The Society of Memorial Sloan Kettering Cancer Center (MSK), an organization of dedicated volunteers, raised an extraordinary $6.6 million in their 2022–2023 season, fueling innovations in cancer care, research, and education.
… Monday, June 10, 2024 The Society of Memorial Sloan Kettering Cancer Center (MSK), an organization of dedicated volunteers, raised an extraordinary $6.6 million in their 2022–2023 season, fueling innovations in cancer care, research, and education. Infographic text: The Society raised an extraordinary
-
News
In this Q&A, medical oncologist Martee Hensley discusses the diagnosis and treatment of leiomyosarcoma and other uterine sarcomas.
… Thursday, July 14, 2016 Summary Memorial Sloan Kettering has a team of experts who specialize in the diagnosis and treatment of uterine sarcomas . Here, medical oncologist Martee Hensley tells us the latest developments in leiomyosarcoma and how our team approach benefits people with these rare cancers
-
News
Women who have reconstructive surgery after mastectomy and radiation for breast cancer are usually more satisfied with the results when their own tissue is used instead of implants.
… Thursday, December 8, 2016 Summary Women undergoing mastectomy for breast cancer have two main options for reconstructive surgery : artificial implants or flap surgery using their own tissue. A new study looked at these options in women who received radiation after mastectomy and found that those whose
-
2023 Annual Report
After Joshy was successfully treated for pediatric kidney cancer at MSK Kids, his family signed up for Cycle For Survival to raise money for rare cancers.
… Monday, June 10, 2024 The MSK Giving community is a mighty force of hundreds of thousands of people united in a common purpose. Each has a story to tell about their reasons for giving. For Vanessa and Josh, it’s their precious son, Joshy. He was just 5 months old when he was diagnosed with a pediatric
-
News
A rarely seen phenomenon in cancer patients — in which focused radiation to the site of one tumor is associated with the disappearance of metastatic tumors all over the body — has been reported in a patient with melanoma treated with the immunotherapeutic agent ipilimumab (Yervoy™).
… Thursday, March 8, 2012 A rarely seen phenomenon in cancer patients — in which focused radiation to the site of one tumor is associated with the disappearance of metastatic tumors all over the body — has been reported in a patient with melanoma treated with the immunotherapeutic agent ipilimumab (Yervoy
-
News
Scientists came to MSK to celebrate the 75th birthday of a leader in the field of structural biology.
… Tuesday, May 16, 2017 Dinshaw Patel Dinshaw Patel Thomas Hermann, University of California San Diego Thomas Hermann, University of California San Diego Lawrence Shapiro, Columbia University Lawrence Shapiro, Columbia University Alexander Serganov, New York University Alexander Serganov, New York University
-
News
DeAngelis is acknowledged for her groundbreaking research in the field of neuro-oncology over her more than 30-year career.
… Friday, September 25, 2020 Memorial Sloan Kettering (MSK) is proud to announce that Physician-in-Chief and Chief Medical Officer Lisa M. DeAngelis, MD, is included on Avenue Magazine ’s The Power List 2020 . The list of more than 50 visionaries within the New York metropolitan area comprises leaders
-
News
MSK researchers moved cancer science ahead in 2015 with landmark discoveries that suggest new treatment strategies and shed light on how the disease progresses.
… Tuesday, December 29, 2015 Microscopic image of spherical cluster of cells, most of them pink cells with a smaller number of blue ones. Microscopic image of a spherical organoid of intestinal cells. Taken from the blog post "Manipulating a Single Gene Turns Colorectal Cancer Cells Back to Normal." See